These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer? Domingues-Ferreira M; Grumach AS; Duarte AJ; De Moraes-Vasconcelos D Med Mycol; 2009 Mar; 47(2):201-5. PubMed ID: 18798115 [TBL] [Abstract][Full Text] [Related]
6. Host factors in defense against fungal infections. Kirkpatrick CH Am J Med; 1984 Oct; 77(4D):1-12. PubMed ID: 6388323 [TBL] [Abstract][Full Text] [Related]
7. New perspectives on the immunology of chronic mucocutaneous candidiasis. Lilic D Curr Opin Infect Dis; 2002 Apr; 15(2):143-7. PubMed ID: 11964914 [TBL] [Abstract][Full Text] [Related]
8. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect]. Rytter M; Schönborn C; Lohrisch I; Haustein UF Z Gesamte Inn Med; 1986 Apr; 41(7):214-6. PubMed ID: 3521108 [TBL] [Abstract][Full Text] [Related]
10. Chronic mucocutaneous candidiasis - an immunological mystery. Rabson AR S Afr Med J; 2007 Nov; 97(11 Pt 3):1190-2. PubMed ID: 18250935 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in cancer treatment. A comparative study with chronic muco-cutaneous candidiasis. Higgs JM Clin Oncol; 1980 Jun; 6(2):95-112. PubMed ID: 6967793 [No Abstract] [Full Text] [Related]
13. Clinical observations on a case of immuno-deficiency and thymoma (Good's syndrome) associated with chronic mucocutaneous candidiasis. Kaneko F; Tsuchiya K; Miura Y; Kishiyama K; Kusakabe Y; Matsumoto S; Watanabe M J Dermatol; 1982 Oct; 9(5):355-65. PubMed ID: 6761378 [No Abstract] [Full Text] [Related]
14. An unusual combination of immunologic abnormalities in a patient with chronic mucocutaneous candidiasis. Gill FF; Portnoy JM Ann Allergy; 1989 Aug; 63(2):98-100, 147-8. PubMed ID: 2669569 [No Abstract] [Full Text] [Related]
15. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis. Barnaba V; Zaccari C; Levrero M; Balsano F Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525 [TBL] [Abstract][Full Text] [Related]
16. [Chronic mucocutaneous candidiasis]. García MP; Puig L; Pérez M; de Moragas JM Med Cutan Ibero Lat Am; 1988; 16(6):445-9. PubMed ID: 3073267 [TBL] [Abstract][Full Text] [Related]
17. Chronic mucocutaneous candidiasis with deficient CD2 (E receptor) but normal CD3 mononuclear cells. Noh LM; Hussein SH; Sukumaran KD; Rose I; Abdullah N J Clin Lab Immunol; 1991 Jun; 35(2):89-93. PubMed ID: 1688166 [TBL] [Abstract][Full Text] [Related]
19. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans. Burford-Mason AP; Matthews RC; Williams JR J Infect; 1987 Mar; 14(2):147-57. PubMed ID: 2952735 [TBL] [Abstract][Full Text] [Related]
20. Case report: familial chronic mucocutaneous candidiasis complicated by deep candida infection. Germain M; Gourdeau M; Hébert J Am J Med Sci; 1994 Apr; 307(4):282-3. PubMed ID: 8160723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]